Physician
Cardiology
Dr. John F. Paolini, MD
|
|
Give Review
John F. Paolini works in the field of Cardiology. He went to Duke University School of Medicine. Duke University School of Medicine is a one of the best medicals schools. Duke University School of Medicine has a rank of 8 in research and a 29 in primary care He received 1 awards: "Fellow (FACC)". John Paolini is also a published doctor. He has 14 paper published. The most recent paper is: Effects of the high-density lipoprotein mimetic agent CER-001 on coronary atherosclerosis in patients with acute coronary syndromes: a randomized trial.
Publications
- Effects of the high-density lipoprotein mimetic agent CER-001 on Coronary atherosclerosis in patients with acute Coronary syndromes: a randomized trial.
- Prevention of stroke and systemic embolism with rivaroxaban compared with warfarin in patients with non-valvular atrial fibrillation and moderate renal impairment.
- Efficacy and tolerability of extended-release niacin/laropiprant in dyslipidemic patients with metabolic syndrome.
- Safety of extended-release niacin/laropiprant in patients with dyslipidemia.
- Flushing profile of extended-release niacin/laropiprant versus gradually titrated niacin extended-release in patients with dyslipidemia with and without ischemic cardi...
- Lipid-modifying efficacy of extended release niacin/laropiprant in Asian patients with primary hypercholesterolemia or mixed Hyperlipidemia.
- Effects of aspirin when added to the prostaglandin D2 receptor antagonist laropiprant on niacin-induced flushing symptoms.
- Blood pressure-lowering effects of extended-release niacin alone and extended-release niacin/laropiprant combination: a post hoc analysis of a 24-week, placebo-control...
- Effects of a niacin receptor partial agonist, MK-0354, on plasma free fatty acids, lipids, and cutaneous flushing in humans.
- Effects of laropiprant on nicotinic acid-induced flushing in patients with dyslipidemia.
- Effects of ezetimibe on cyclosporine pharmacokinetics in healthy subjects.
- Interaction of single-dose ezetimibe and steady-state cyclosporine in renal transplant patients.
- Simvastatin does not have a clinically significant pharmacokinetic interaction with fenofibrate in humans.
Schools
Duke University
Brigham and Women39s Hospital
Conditions Treated
- Aortic Ectasia
- Cardiomyopathy
- Coronary Artery Disease (CAD)
- Hyperlipidemia
- View All
Doctors Specialties
- Cardiology
Accepted Insurances
Awards
- Fellow (FACC)
Education
-
Brigham and Women's Hospital -
Duke University School of Medicine
Helpful Reviews
Similar Doctors
|
|
Dr. Hagop Margossian, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Michael A. Deangelis, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Praveen Mehrotra, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Shelley R. Hankins, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Irina M. Joukova, MD
This Doctor is OpenDoctor Recommended.
|